Clinical Trial Update: A Study Of Valsartan Used To Treat Hypertension For Up To 13 Months In Hypertensive Children Ages 6 - 16 Years Of Age [Phase 3]

View source ↗

Summary

This clinical trial update reports on a Phase 3 study evaluating valsartan for treating hypertension in children aged 6 to 16, with follow-up up to 13 months. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• VALSARTAN (Valsartan)

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 3 | Status: COMPLETED